The WHO Framework Convention on Tobacco Control (FCTC) recently concluded in Moscow and included the adoption of several landmark decisions.
Researchers have discovered an inhibitor for an enzyme called Sphingomyelin phosphodiesterase C (SMaseC) which is produced by the S. aureus bacterium and may harm the health of CF patients.
UCSF researchers have identified a novel factor that puts the brakes on airway smooth-muscle contraction relevant to asthma.
Royal Philips and Radboud University Medical Center (Nijmegen, Netherlands) have launched a prototype monitoring device to support patients with COPD.
The United States has fallen far behind much of the world in requiring large, graphic health warnings on cigarette packs, according to the Campaign for Tobacco-Free Kids.
The FDA has issued 510(k) clearance for the Nellcor Portable SpO2 Patient Monitoring System (PM10N), according to a Covidien announcement.
The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase IIb study evaluating benralizumab in patients with severe, uncontrolled asthma and elevated levels of eosinophils.
Covidien will support a two-year campaign by the AAMI Foundation’s National Coalition for Alarm Management Safety to improve alarm management in healthcare.
A new clinical study is treating COPD patients with an investigational procedure called Targeted Lung Denervation, which results in smooth muscle relaxation throughout the lungs.
Fifty years after the 1964 Surgeon General’s report, Marlboro is still selling 111 billion packs of cigarettes a year, good for a 40% share of the market and a profitability of 32%.